We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Implantable Defibrillator Series MRI Compatible

By HospiMedica International staff writers
Posted on 15 Apr 2013
An advanced cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) series can be used during magnetic resonance imaging (MRI) procedures.

The Iforia series of ICD/CRT-D devices feature ProMRI technology, which enables access to potentially life-saving MR scans when needed. More...
The Iforia series also includes the industry standard DF4 connector system, designed to simplify and shorten the implantation procedure by combining the traditional three connectors into one, allowing for a more convenient implantation procedure without compromising safety. It also reduces the material in the insertion pocket, the risk of lead-to-port mismatch, and may also lower the risk of lead abrasion.

The Iforia series also offer several of the smallest ICDs and CRT-Ds on the market, as well as marked longevity, with the Iforia single chamber ICD reaching more than 11 years, while the Iforia CRT-D has a longevity of more than 7 years. This allows for a low replacement rate, offering clear benefits for both patients and the health care system. The series also includes secure remote monitoring via a Home Monitoring feature. The Iforia series of ICD/CRT-D devices are products of BIOTRONIK (Berlin, Germany), and has received the European community CE marking of approval.

“BIOTRONIK has consistently driven innovation since its foundation in 1963. In the past 15 months alone, BIOTRONIK received market approval for two series of ICDs and CRT-Ds, both of which enable patients to have access to MR scans. The new Iforia series, combined with ProMRI and BIOTRONIK Home Monitoring, offers physicians and patients the best combination of reliability and innovation,” said Christoph Böhmer, President International of BIOTRONIK.

“With the Iforia series I can provide my patients with a small and highly reliable ICD and CRT-D series. It includes an impressive range of state-of-the-art innovations including ProMRI and home monitoring,” said Ching Chi Keong, MD, of the National Heart Centre (Singapore). “In addition the DF4 technology simplifies the implantation procedure, while the small size of the device makes it more comfortable for the patient and also leads to a better cosmetic result.”

Related Links:

BIOTRONIK



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.